Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial - Wikidata - wikimedia - TriplyDB

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial

http://www.wikidata.org/entity/Q30876278

about

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression Omega-3 fatty acids for depression in adults Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology ω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane review Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements Comments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.Omega-3 fatty acids and cognitive function in women.Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals.Perinatal depression and omega-3 fatty acids: a Mendelian randomisation study.Depression and cardiovascular disease: selected findings, controversies, and clinical implications from 2009 Effect of obstructive sleep apnea on response to cognitive behavior therapy for depression after an acute myocardial infarction Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders.Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers.Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction.Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.High potency fish oil supplement improves omega-3 fatty acid status in healthy adults: an open-label study using a web-based, virtual platform.How Should We Treat Depression in Patients with Cardiovascular Disease?Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.Depression and the heart.Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.Marine omega-3 fatty acids and mood disorders--linking the sea and the soul. 'Food for Thought' I.Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link.The use of omega-3 fatty acids in mental illness.Omega-3 polyunsaturated fatty acids for major depressive disorder.Five potential therapeutic agents as antidepressants: a brief review and future directions.Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia.Evidence for Inflammation-Associated Depression.Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis.High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression.

P2860

Q22305455-1D9D7306-F3A4-4AF4-9019-19E8881DB0EC Q24187951-893AB107-3988-4C5B-BDF8-A6B3C581C8BB Q24634019-69D1F4B4-47EB-4B3F-BF2F-9D5229042766 Q26740508-DD1530C6-991E-4D05-94DB-15AA492F76A3 Q28072641-068E04CC-12CE-4208-A5B0-765ADCD6DE41 Q28076799-02093082-4B38-46DB-997F-39105A52EDF0 Q31050854-E0E2B9ED-E750-4F56-A682-B65A8652EE13 Q31121789-386D2B17-B94C-42B3-AABB-2E6FA39CD04E Q33351796-A98875A2-6B72-4744-8F9D-BAB1A6C907C7 Q33578486-D04F871C-A572-461C-A702-E2149FB41DA3 Q33661294-7C3AE934-E9B5-4862-8C4A-EF4AA458F6BD Q33677382-49A9E74D-475B-4B55-93A4-B70F1600BFFF Q33852181-78087C21-FA7C-4504-821D-E91DFCE78667 Q33912160-879E73A8-5FB0-4900-80ED-5DAB49F6325E Q34051574-6111521E-5FD1-44B7-81D3-F2ED9A32BFD8 Q34190316-9AF7742D-6603-4094-A933-A43EAA1242FC Q34275382-C86227A8-D8C5-4191-9A80-7D7522949215 Q34322681-B8EA7074-1482-43D6-AC1B-89E712C996EC Q35046651-C8FE91A2-4D6B-4926-9318-0CC607FC747F Q35656411-CBEDE9E6-BF14-4645-A5CF-10403E1CDCD1 Q35670890-1A7C6F7F-BDB1-4868-8287-33626AFD9FD2 Q36294918-753792E7-49EF-4E80-81BF-763ADE922AA0 Q36616072-717F1F21-F124-4EBA-BD25-D625FE6E61D6 Q36915538-FAABEBCA-E967-4F77-9365-549FA8DAD2D8 Q37114699-56D6AACA-B3A3-40B7-AA69-9804E66777AF Q37166433-7536E06D-E256-4A07-B4BA-474FEF4E4C79 Q37244564-F287E335-9B0F-4695-92F8-2A20654D506D Q37387750-2F883699-63B8-4FD1-9D0F-D69F280FD342 Q37528323-F0045109-F8E6-471E-AEF4-C80C63F52D26 Q37863685-B1020CE3-7CCA-4DC3-9A5B-705EDBF78169 Q37905722-50619D59-EB14-4140-AD2C-BC0DD342EAAB Q37937303-68E6D79E-07AC-4EAE-90DA-B483735EE684 Q38148244-3C09C950-766D-4B88-9705-D457ED1432AA Q38574831-8CE0B335-DA4E-4EA9-A1AF-E445F26F5223 Q38701079-F912BF81-A6AD-49EE-AF31-874BF73A7573 Q38843528-5B892FD0-0438-4CE6-9DFB-74AD70C32C7F Q48701739-96905F21-10EF-4368-B47B-9A86654F1B3E Q48793808-B197A473-760B-47EB-BD34-7FFBDA44E63F

P2860

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial

http://www.wikidata.org/entity/Q30876278

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Omega-3 augmentation of sertra ...... a randomized controlled trial

@ast

Omega-3 augmentation of sertra ...... a randomized controlled trial

@en

type

label

Omega-3 augmentation of sertra ...... a randomized controlled trial

@ast

Omega-3 augmentation of sertra ...... a randomized controlled trial

@en

prefLabel

Omega-3 augmentation of sertra ...... a randomized controlled trial

@ast

Omega-3 augmentation of sertra ...... a randomized controlled trial

@en

P1433

Q30876278-72C5A40B-BEC2-4B30-8D53-7206841E34BB

P1476

Q30876278-78F9D1B8-052F-4121-904B-03F8679FC144

P2093

Q30876278-17C4232F-A3C9-4BAA-9FCA-4085F9D3D4F6

Q30876278-4348489D-8D69-4CD0-96F3-975220B3D9C7

Q30876278-57DF0627-9F60-4E80-97CD-487D11E38FF8

Q30876278-7AFA257E-F4D0-46EB-85ED-A5F9703658F8

Q30876278-94F32AF3-0DE1-4077-8DBC-BE6E923081BD

Q30876278-BDEB45F8-2AAB-44D2-A2A1-31F9B41F2846

P2860

Q30876278-00270014-70FE-4E08-9F53-386B0B161CEE

Q30876278-083842CF-BABB-493C-B9C2-C666E8E89558

Q30876278-08FF50AF-17D0-4F8A-9535-70A7A6BA8219

Q30876278-0BE840AA-00B7-4300-AA23-495343ED1676

Q30876278-11E7746A-585A-414E-B263-38F8C6AD9E65

Q30876278-1DD321EE-D38B-4975-B0FD-53D52E229FEB

Q30876278-21B61933-72B7-4885-909C-70755C18BC96

Q30876278-2A4454AF-8FC8-4616-81E8-9A1015F961E9

Q30876278-358FE6C2-F605-43D0-9373-64A400E559BF

Q30876278-398C0F0F-D9DA-436E-BCEB-683A53DCC046

P304

Q30876278-16D36E91-40FC-41BF-9679-D0178695D052

P31

Q30876278-83D1D995-8832-4E67-8A1B-F02E48480E6D

P356

Q30876278-5AC6019A-A7E0-4AEA-A3F8-1185A4FD6785

P407

Q30876278-AA3D5806-A23A-4F42-8B07-6FC055079509

P433

Q30876278-0D8EA652-E04E-4B4C-A541-4E5322E3E96D

P478

Q30876278-9AC664A7-8E85-45A9-A330-6E81D9683071

P577

Q30876278-57F41B64-8995-45ED-A7C6-4913524CF2DE

P5875

Q30876278-1CBE93B9-C439-43BE-9693-866056E843E4

P698

Q30876278-FB945640-71F1-4D23-9DE8-C100E7567AFD

P932

Q30876278-4D225CC6-1170-4F37-B7F1-A8D6D06FF7DF

P356

P1433

Journal of the American Medical Association

P1476

Omega-3 augmentation of sertra ...... a randomized controlled trial

@en

P2093

Brian C Steinmeyer

http://www.w3.org/2001/XMLSchema#string

Eugene H Rubin

http://www.w3.org/2001/XMLSchema#string

Kenneth E Freedland

http://www.w3.org/2001/XMLSchema#string

Michael W Rich

http://www.w3.org/2001/XMLSchema#string

Robert M Carney

http://www.w3.org/2001/XMLSchema#string

William S Harris

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls

An inventory for measuring clinical anxiety: psychometric properties

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.

Depression in patients with coronary heart disease.

Effect of fish oil on arrhythmias and mortality: systematic review.

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.

P304

1651-1657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2009.1487

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38024873

http://www.w3.org/2001/XMLSchema#string

P698

19843899

http://www.w3.org/2001/XMLSchema#string

P932

3477788

http://www.w3.org/2001/XMLSchema#string